相关实验视频

Updated: Jun 24, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

纳米复合物水凝 - - 一个有前途的方法,提高生物可用性和控制药物输送

Nariman Shahid¹, Alia Erum², Sana Hanif¹

¹Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.

Current pharmaceutical design

|December 29, 2023

概括

基于聚合物的纳米复合物水凝 (NCHs) 通过结合纳米粒子和水凝提供先进的药物输送解决方案. 这些材料对各种生物医学应用,包括组织工程和癌症治疗有很大的前景.

科学领域:

材料科学材料科学材料科学
生物医学工程生物医学工程
纳米技术纳米技术

背景情况:

传统的药物输送系统面临着纳米技术旨在解决的挑战.
基于聚合物的纳米复合物水凝 (NCHs) 正在成为控制药物输送的先进载体.
NCHs将纳米粒子 (NP) 与水凝集成,提供增强的机械,电,光学和磁性性能.

研究的目的:

审查基于聚合物的纳米复合物水凝 (NCHs) 的制备方法和生物医学应用.
突出NCHs在药物输送中比传统水凝具有的优势.
讨论NCHs的调节性质和未来前景.

主要方法:

概述不同类型的NCHs,包括那些基于碳纳米材料,聚合物纳米粒子和无机纳米粒子.
讨论NCHs的制备技术.
对各种生物医学应用的审查.

主要成果:

与传统的水凝相比,NCHs具有增强的机械,电,光学和磁性质.
在组织工程,药物输送,伤口愈合,生物传感,癌症治疗和抗菌应用方面,NCHs具有显著的潜力.
NCHs的可调节性质允许特定应用的设计和受控的药物释放.

结论:

纳米复合材料水凝代表了药物输送系统的重大进步.
目前正在进行的研究和未来前景表明,NCHs在各种生物医学领域的发展轨迹充满希望.
调整NCH特性的能力使得它们在针对性治疗干预中具有高度的多功能性.

关键词:

纳米技术纳米技术生物医学应用.传统的药物输送系统.纳米复合材料的水凝.新的交付系统.聚合物纳米粒子的聚合物纳米粒子.

更多相关视频

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

相关概念视频

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Bioavailability

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...

Modified-Release Drug Delivery Systems: Stimuli-Activated

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...